The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery  by Kilicaslan, Fethi et al.
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n Patients With and Without Previous Cardiac Surgery
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ussama Wazni, MD,* Jennifer E. Cummings, MD,* Steven Hao, MD,† Michelle Williams Andrews, RN,*
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. David Burkhardt, MD,* Walid Saliba, MD,* Robert A. Schweikert, MD,* Andrea Natale, MD*
leveland, Ohio; and San Francisco, California
OBJECTIVES The aim of this study was to assess the incidence of atrial flutter (AFL) after pulmonary vein
antrum isolation (PVAI) in patients with previous cardiac surgery (PCS) in comparison to
patients without PCS and to assess the need for AFL ablation in both groups.
BACKGROUND Atrial fibrillation (AF) and AFL often co-exist. Pulmonary vein antrum isolation may be
sufficient to control both arrhythmias. However, in patients with PCS, atrial incisions,
cannulations, and scar areas may cause AFL recurrence despite elimination of pulmonary vein
triggers.
METHODS Data from 1,345 patients who had PVAI were analyzed. Patients with a history of AFL
ablation and patients who had concomitant AFL ablation during PVAI were excluded from
analysis. Sixty-three patients constituted the PCS group (Group 1, age 57  13 years, 12
female) and 1,062 patients constituted the non-PCS group (Group 2, age 55  12 years, 212
female). Patients in Group 1 had larger left atria, higher incidence of AFL pre-PVAI, and
lower ejection fraction.
RESULTS There was no significant difference in post-PVAI AF recurrence between Groups 1 and 2, but
AFL incidence after PVAI was higher in Group 1 (33% vs. 4%, p  0.0001). Ablation of
AFL in Group 1 patients resulted in an 86% acute success rate and 11% recurrence over a
mean follow-up of 357  201 days.
CONCLUSIONS In patients with PCS, post-PVAI AF recurrence is similar to patients without PCS.
However, history of PCS is associated with a higher recurrence of AFL after PVAI. In a
significant number of patients with PCS, AFL ablation is required to achieve a cure. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.047Coll Cardiol 2005;45:690–6) © 2005 by the American College of Cardiology Foundation
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1trial flutter (AFL) is an important late complication after
ardiac surgery with increasing morbidity and mortality over
ime (1–3). The mechanism of AFL occurring after a
emote previous cardiac surgery (PCS) is well characterized.
he AFL in these patients is re-entrant, and the flutter
ircuit may involve atypical isthmuses between natural
arriers, atrial incisions, and scar areas as well as the
avotricuspid isthmus (2–5).
There is a close relationship between atrial fibrillation
AF) and AFL. They often co-exist in the same patient and
ay degenerate into each other (6–9). Pulmonary vein (PV)
riggers may be responsible for initiation of AFL as well as
F (7,10,11). Pulmonary vein antrum isolation (PVAI) is a
easible and effective treatment for patients with symptom-
tic and drug-resistant AF, even for patients with PCS
12,13). In patients without a history of PCS, we have
hown previously that PVAI is sufficient to control both AF
nd AFL (10). However, in patients with PCS, the poten-
ial for AFL isthmuses secondary to PCS and a very
From the *Cleveland Clinic Foundation, Section of Pacing and Electrophysiology,
leveland, Ohio; and †Sutter Pacific Heart Centers, San Francisco, California.p
Manuscript received August 23, 2004; revised manuscript received October 20,
004, accepted November 15, 2004.nstable substrate may predispose to AFL recurrence de-
pite the elimination of PV triggers. Whether AFL recur-
ence after PVAI is different in patients with and without
CS is unknown.
We sought to: 1) assess the incidence of AFL after PVAI
n patients with PCS in comparison to patients without
CS, and 2) establish whether additional AFL ablation is
equired in these patients.
ETHODS
atient population. Data from 1,345 patients who had
VAI at two institutions between October 2000 and
ecember 2003 were analyzed. Patients with a history of
FL ablation and patients who had concomitant AFL
blation during PVAI were excluded from analysis. Sev-
nty patients had a history of PCS 6 months ago.
mong them, five patients were excluded because of a
istory of AFL ablation and two patients were excluded
ecause of concomitant AFL ablation during the PVAI
rocedure, leaving 63 patients in the PCS group (Group
, age 57  13 years, 12 female). Of the remaining 1,275
atients, 189 were excluded because of either a previous
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VAI procedure, leaving 1,062 patients in the non-PCS
roup (Group 2, age 55  12 years, 212 female). Patients
ho had AF and AFL recurrence concomitantly were
onsidered for repeat PVAI and AFL ablation. An AFL
blation alone was considered if AFL was the only
rrhythmia documented with recurrence. The PVAI
esult, AFL recurrence, and result of additional AFL
blation in both groups were compared. All patients
igned written informed consent before the procedure,
nd patient data were collected in accordance with
nstitutional ethics guidelines.
VAI. All patients underwent PVAI using an intracardiac
chocardiography-guided technique as described previously
12). Briefly, a 10-F 64-element phased-array ultrasound
atheter (Siemens AG, Malvern, Pennsylvania) was posi-
ioned in the right atrium (RA) via the right femoral vein.
decapolar circular (Lasso) mapping catheter and an
-mm-tip ablation catheter (Biosense Webster, Diamond
ar, California) were advanced into the left atrium (LA) via
wo trans-septal punctures. Radiofrequency (RF) ablation
as performed wherever PV potentials were recorded
round the PV antrum. Intracardiac echocardiography was
sed to guide trans-septal puncture, to define the pulmonary
enous antra, to guide sequential placement of the Lasso
atheter in all positions around PV antra, and to detect
icrobubble formation for RF energy titration. The RF
solation of the PV was considered complete when all PV
otentials surrounding the vein antrum were abolished. All
our PVs and the superior vena cava were isolated in every
atient. Patients were heparinized during the procedure to
aintain an activated clotting time of 350 to 400 s.
Warfarin was discontinued 48 h before the procedure. All
ntiarrhythmic drugs except amiodarone (which was discon-
inued four to five months before) were discontinued at least
ve half-lives before the ablation procedure. All patients had
ransesophageal echocardiography before the PVAI proce-
ure to exclude intracardiac thrombi.
apping and ablation of AFL. The mapping and ablation
f AFL was performed as described in detail elsewhere
Abbreviations and Acronyms
AF  atrial fibrillation
AFL  atrial flutter
ASD  atrial septal defect
AVR  aortic valve replacement
CABG  coronary artery bypass graft surgery
LA  left atrium/atrial
MVR  mitral valve replacement
PCS  previous cardiac surgery
PV  pulmonary vein
PVAI  pulmonary vein antrum isolation
RA  right atrium/atrial
RF  radiofrequency5,14). All patients had standard electrophysiologic testing dith electrode catheters placed in the coronary sinus, high
A, and His bundle positions. Intracardiac electrograms as
ell as simultaneous electrocardiographic leads were re-
orded using a multi-channel recording system (CardioLab,
rucka GE Medical, Waukesha, Wisconsin). Three-
imensional electroanatomic mapping was performed in all
atients using the CARTO electromagnetic mapping sys-
em (Biosense Webster Inc.). Mapping was performed with
4-mm-tip ablation catheter (Navistar, Biosense Webster
nc.). On CARTO, “electrically silent areas” were defined as
reas with no electrogram or with bipolar voltage amplitude
ndistinguishable from noise (0.05 mV).
If the patient presented in normal sinus rhythm, AFL was
nduced by atrial programmed stimulation or burst pacing.
n electroanatomic activation map of the RA was created
uring AFL; potential critical isthmuses were identified by
oncealed entrainment mapping as previously described
2,15). If there were no critical RA isthmuses, LA access
as obtained via trans-septal puncture and electroanatomic
apping, and entrainment mapping was repeated in the
A.
The RF lesions were applied depending on the underly-
ng AFL mechanism: 1) between the tricuspid annulus and
he Eustachian ridge, 2) between two scars, or 3) between a
car and an anatomic barrier (valve, vena cava, or PV). In
atients with typical right AFL, bidirectional block was
emonstrated by pacing at different sites and using the
ARTO system. In patients with atypical AFL, ablation
as continued until there was at least 90% reduction of
lectrographic amplitude along the ablation line. Block
cross the line was demonstrated using the CARTO map-
ing system when possible. Double potentials with a sepa-
ation of 90 ms were required along the ablation line. To
ssess the success of the ablation, inducibility of AFL was
ested after ablation using both programmed and burst
acing.
ollow-up. All patients were discharged home the day
fter the procedure. Patients were followed in the outpatient
linic at 3, 6, and 12 months after ablation. A rhythm
ransmitter was used in all patients to monitor events during
hree months after ablation, and this was extended by
nother three months for patients with recurrence of symp-
oms. Patients were asked to transmit their rhythm three
imes per day and every time they had symptoms compatible
ith arrhythmia. In all patients, 48-h Holter recording was
one routinely immediately after the procedure and at the
-, 6-, and 12-month follow-up visits. For analysis, recur-
ence of AFL and AF was considered only after eight or
ore weeks after PVAI (10,12). Warfarin (international
ormalized ratio 2 to 3) was restarted in all patients the day
f PVAI and was continued for a minimum of four to six
onths. Antiarrhythmic drugs were restarted in all patients
he day of PVAI and continued only for two months; these
rugs were chosen from sotalol, propafenone, flecainide, or
ofetilide. Amiodarone was not used after ablation.
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AFL Ablation After PVAI in Patients With PCS March 1, 2005:690–6tatistical analysis. Continuous variables are expressed as
ean values  SD. Continuous variables were compared by
he independent-samples unpaired Student t test. Categor-
cal variables were compared by chi-square analysis. A value
f p  0.05 was considered significant for all statistical
eterminations.
ESULTS
aseline characteristics. Group 1 and Group 2 patients
id not differ in their age, duration, and type of AF, but
roup 1 patients had larger LA diameter (4.7  0.7 cm vs.
.4  0.6 cm, p  0.0001), higher incidence of AFL
iagnosis before PVAI (38% vs. 22%, p 0.005), and lower
jection fraction (49  10 vs. 54  8, p  0.0001).
wenty-four (38%) patients in Group 1 had documented
FL at baseline (16 typical, 8 atypical) compared with 234
22%) patients in Group 2 (230 typical, 4 atypical)
p  0.005). The baseline demographics of the groups are
hown in Table 1.
In patients with PCS, the cardiac surgery was coronary
rtery bypass graft surgery (CABG) in 26, mitral valve
eplacement (MVR) in 22, aortic valve replacement (AVR)
n 5, AVR  CABG in 1, MVR  CABG in 1, MVR 
trial septal defect (ASD) in 1, MVR and AVR in 1,
ombined MVR  AVR  ASD in 1, ASD in 4, and
ricuspid valve surgery in 1. The mean time period between
ardiac surgery and the PVAI date was 7.6  5.2 years.
VAI results. All four PVs were isolated successfully in all
atients in Group 1 and Group 2 (fluoroscopy time 80 27
in vs. 79  25 min, p  0.84). After PVAI, 13 (21%)
atients in Group 1 and 201 (19%) patients in Group 2 had
Table 1. Baseline Demographics
Group
Women (n) 1
Age (yrs) 5
Left atrial diameter (cm) 4
Mean LVEF (%) 4
Duration of AF (yrs) 6
Hypertension (n) 2
Type of AF (n)
Paroxysmal 3
Persistent
Permanent 2
Failed AADs (n) 2
AAD before PVAI (n)
Sotalol
Dofetilide 1
Propafenone
Flecainide
Beta-blocker/digitalis 1
Others 1
AFL diagnosis before PVAI, patient (n) 2
Typical
Atypical
*p  0.05.
AAD antiarrhythmic drugs; AF atrial fibrillation; AF
 pulmonary vein antrum isolation.ecurrence of AF during a mean follow-up period of 508  u99 days and 548  282 days, respectively (p  0.31). No
ajor complication related to PVAI was seen in Group 1. In
roup 2, seven patients (0.7%) had cerebroembolic complica-
ions, four patients (0.4%) had moderate to severe PV stenosis,
nd two patients (0.2%) had pericardial effusion. Data regard-
ng PVAI results are summarized in Table 2.
The AFL recurrence after PVAI was significantly higher
n Group 1 compared with Group 2 (33% vs. 4%, p 
.0001). In Group 1, 21 patients had AFL recurrence
typical in 7, atypical in 14), whereas in Group 2, 43 patients
ad AFL recurrence (typical in 28, atypical in 15). Among
atients who had AFL diagnosis before PVAI, 15 of 24
atients (63%) in Group 1 and 219 of 234 patients (94%) in
roup 2 were free of AFL after PVAI.
FL ablation. All 21 Group 1 patients who had AFL
ecurrence underwent AFL ablation. Four patients in this
roup had concomitant AF recurrence and a second PVAI
as done before AFL ablation at the same session. Details
f the ablation procedure and AFL are given in Table 3.
uring the ablation procedure, a total of 33 AFLs (15
ypical, 18 atypical) were identified in the 21 patients. Ten
f 21 Group 1 patients (48%) with AFL recurrence had
ultiple AFL isthmuses and required multiple isthmus
blations. Of all the AFLs, 30 of 33 (91%) were ablated
uccessfully without complication, representing 18 of 21
atients (86%). Interestingly, all three patients with unsuc-
essful AFL ablation had a history of MVR and had AFL,
hich was atypical and mapped to LA. During a mean
ollow-up of 357  201 days, 2 of 18 patients (11%) who
ad successful AFL ablation had AFL recurrence.
All 43 patients in Group 2 who had AFL recurrence
 63) Group 2 (n  1,062) p Value
) 212 (20%) 0.99
13 55  12 0.24
0.7 4.4  0.6  0.0001*
10 54  8  0.0001*
6.4 6.6  5.5 0.67
) 203 (19%) 0.001*
) 605 (57%) 0.69
) 138 (13%) 0.99
) 319 (30%) 0.57
1.2 2.7  1.2 0.77
) 161 (15%) 0.72
) 148 (14%) 0.71
%) 92 (9%) 0.65
%) 115 (11%) 0.40
) 290 (18%) 0.98
) 151 (14%) 0.46
) 234 (22%) 0.005*
230
4
trial flutter; LVEF left ventricular ejection fraction; PVAI1 (n
2 (19%
7 
.7 
9 
.9 
4 (38%
4 (54%
8 (13%
1 (33%
.6 
8 (13%
0 (16%
4 (6.5
4 (6.5
7 (27%
1 (17%
4 (38%
16
8nderwent AFL ablation. Three of 43 patients (7%) in
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March 1, 2005:690–6 AFL Ablation After PVAI in Patients With PCSroup 2 had multiple AFL isthmuses and needed multiple
sthmus ablations. In this group, 22 patients had concomi-
ant AF recurrence and a second PVAI was performed
oncomitant with AFL ablation at the same session. The
FL ablation was successful in all (100%), and no compli-
ation related to AFL ablation was noted. During a mean
ollow-up of 378  197 days, 2 of 43 patients (5%) had
FL recurrence.
ISCUSSION
ain findings. The main finding of this study is that
atients with PCS have higher AFL recurrence after PVAI
ompared with patients without previous PCS. In addition,
FL ablation is needed in a higher number of patients with
CS and can be performed effectively. To our knowledge,
his is the first study to compare AFL occurrence after
VAI in patients with and without PCS.
VAI as a treatment for AFL. It is well recognized that
FL and AF often co-exist and may degenerate into each
ther (6–9). Also, a considerable number of patients have
F recurrence after ablation of typical AFL (16). The
easons for co-existence are not entirely clear, but it is
ossible that PV triggers may initiate AFL as well as AF, or
ay convert AFL to AF (7,10,11). We have reported, for
xample, that in patients with both typical AFL and AF,
VAI alone was sufficient to control both arrhythmias (10).
he results presented in this series are consistent with our
revious report. Indeed, 94% (219 of 234) of patients who
ad pre-existing AFL were cured by PVAI alone in the
ontrol group (Group 2). In contrast, only 15 of 24 PCS
atients (63%) with pre-PVAI AFL were free of AFL after
VAI. Furthermore, 21 (33%) PCS patients experienced
FL occurrence after PVAI. These results demonstrate that
he elimination of PV triggers may not prevent the occur-
Table 2. PVAI Results and Follow-Up
Mean fluoroscopy time (min)
Mean procedure time (h)
Mean follow-up period (days) 5
AF recurrence (n)
Electrically silent areas in LA/RA (n)
AAD after PVAI
Sotalol
Dofetilide
Propafenone
Flecainide
Beta-blocker/digitalis
Others
AFL recurrence within two months (n)
AFL recurrence after two months (n)
Typical AFL
Atypical AFL
*p  0.05.
LA  left atrium; RA  right atrium; other abbreviationence of AFL in a significant number of patients with PCS. possible mechanisms of high AFL incidence in PCS
atients after PVAI. A substrate and a trigger are essential
rerequisites to initiate re-entrant AFL (9,17). The PCS
atients may be predisposed to AFL because of the co-
xistence of incision lines, cannulation sites, scars, and
onventional anatomic barriers (4,5,17,18). Areas of low
oltages may also be found at discrete areas other than
ncisions and cannulation sites (4,18). Scars may result from
nterruption of arterial supply, insufficient protection during
ardioplegia, and other surgical trauma (4,18). Furthermore,
car areas may be a manifestation of the underlying struc-
ural heart disease (19). Concordant with these hypotheses,
he present study found that patients with PCS were more
ikely to have electrically silent areas and larger LA diameter
ompared with patients without PCS. These associations
ay reflect a more vulnerable substrate for AFL in patients
ith PCS (20).
In patients who have AF and AFL postoperatively, a high
ncidence of premature atrial beats has been reported before
he onset of atrial arrhythmias (21). Premature atrial beats
rom areas other than the PVs may predispose patients to
FL if the appropriate substrate exists to perpetuate AFL
21,22). Indeed, it has been previously observed that pre-
ature atrial beats and irregular atrial activity often precede
FL (9,23,24). Because PCS patients have the appropriate
rrhythmogenic substrate, they may have higher AFL re-
urrence as a result of triggers outside of the PVs.
Early recurrence of AF and AFL is more common after
VAI for the first two months. This is considered a
ransient finding and may not require long-term treatment
10,12). In the study by Wazni et al. (10), for example, early
FL recurrence (within the first two months after the
VAI procedure) was seen in 55% of patients, but long-
erm AFL recurrence was seen in only 5% of patients. In the
resent study, 18% (192 of 1,062) of patients without
p 1
63)
Group 2
(n  1,062) p Value
27 79  25 0.84
1.2 3.9  1.3 0.65
299 548  282 0.31
1%) 201 (19%) 0.74
0%) 26 (2%)  0.0001*
7%) 126 (12%) 0.23
7%) 151 (14%) 0.46
%) 46 (4%) 0.98
%) 92 (9%) 0.36
5%) 164 (15%) 0.99
7%) 170 (16%) 0.73
0%) 192 (18%)  0.0001*
3%) 43 (4%)  0.0001*
1%) 28 (3%)
2%) 15 (1%)
Table 1.Grou
(n 
80 
3.8 
08 
13 (2
19 (3
11 (1
11 (1
2 (3
3 (5
9 (1
11 (1
38 (6
21 (3
7 (1
14 (2revious PCS and 60% (38 of 63) of patients with PCS had
Table 3. Characteristics of AFL in PCS Patients
Patient
No.
Age
(yrs) Gender
Pre-PVAI
AFL
AF
Recurrence
After PVAI
Induced AFL
(During AFL
Ablation) CL (ms)
Electrically
Silent Areas
Previous
Cardiac
Operation AFL Circuit Ablation Site
Ablation
Result
AFL
Recurrence
After AFL
Ablation
1 40 M No Yes T/AT 260/315 RA PL CABG Around CTI and
RA scar
CTI/RA posterior
near IVC
Success Yes (Atypical)
2 75 F No No AT 455 No CABG Around LSPV and
LA appendage
LA posterior near
LSPV
Success No
3 45 M AT Yes T/AT/AT 280/320/350 RA lateral MVR Around CTI and
RA scar
CTI/RA lateral/RA
high septum
Success No
4 67 M T No T/AT 360/540 RA lateral CABG Around CTI and
RA scar
CTI/RA posterior Success No
5 83 M No Yes T/AT 500/445 RA posterior AVR Around CTI and
RA scar
CTI/RA lateral Success No
6 70 M T No AT 290 RA lateral CABG Around RA lateral
scar
RA PL Success No
7 63 M T No T 270 No MVR Around CTI CTI Success No
8 55 F AT Yes T/AT/AT 350/410/460 RA PL MVR Around CTI, RA
scar, and superior
PVs
CTI/RA posterior/
LA posterior
Failure —
9 66 M T No T 280 No MVR Around CTI CTI Success No
10 29 F No No T/AT 225/298 RA/LA posterior MVR Around CTI and
MVA
CTI/MVA Failure —
11 42 M T No T/AT 250/515 LA posterior MVR Around CTI and LA CTI/LA posterior Success No
12 61 M No No AT 464 No CABG Around superior PVs LA posterior near
LSPV
Success No
13 26 M AT No AT 530 RA/LA posterior MVR Around MVA MVA Success Yes (Atypical)
14 51 M No No AT 290 LA posterior MVR Around LA scar LA posterior Failure —
15 39 F AT No AT 346 No MVR Around IVC RA lateral Success No
16 58 M No No T/AT 260/290 LA posterior MVR Around CTI and
PVs
CTI/LA PL Success No
17 62 M No No T 240 RA PL MVR ASD Around CTI CTI Success No
18 56 F No No T 360 No CABG Around CTI CTI Success No
19 65 M No No T/AT 345/460 LA PL MVR Around CTI and LA
scar
CTI/LA lateral Success No
20 54 M No No T 225 No MVR Around CTI CTI Success No
21 43 M No No T/AT 270/360 RA PL CABG Around CTI and
RA scar
CTI/RA lateral Success No
AF  atrial fibrillation; AFL  atrial flutter; ASD  atrial septal defect; AT  atypical; AVR  aortic valve replacement; CABG  coronary artery bypass surgery; CL  cycle length; CTI  cavotricuspid isthmus; IVC  inferior
vena cava; LA  left atrium; LSPV  left superior pulmonary vein; MVA  mitral valve annulus; MVR  mitral valve replacement; PCS  previous cardiac surgery; PL  posterolateral; PV  pulmonary vein; PVAI  pulmonary
vein antrum isolation; RA  right atrium; T  typical.
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March 1, 2005:690–6 AFL Ablation After PVAI in Patients With PCSarly AFL during the first two months. However, only 4%
f patients without PCS continued to have AFL, whereas
3% of PCS patients had long-term AFL that required
blation. This indicates the persistent nature of the arrhyth-
ogenic substrate in patients with PCS.
FL ablation in patients with and without PCS. Both
he cavotricuspid isthmus-related circuit and other atypical
ircuits can cause AFL in patients with PCS, and both types
f circuits might co-exist in the same patient (5). An AFL
ecurrence rate of 10% to 60% after AFL ablation has been
eported in patients with PCS (3,5,25,26). Several groups
ave shown that to achieve long-term cure, all potential
sthmuses have to be identified and ablated in these patients
5,27,28). Indeed, in the present study, 48% of Group 1
atients with AFL recurrence had multiple AFL isthmuses.
n the other hand, only 7% of Group 2 patients had
ultiple AFL isthmuses requiring ablation.
tudy limitations. This was a retrospective study, and it is
herefore subject to limitations inherent in retrospective
ata analysis. However, all of the data used in this study
ere collected prospectively in a systematic database.
The AFL after PV isolation has been reported as a
omplication secondary to RF ablation around the PV ostia,
nd it could be argued that the AFL occurring after PVAI
ere secondary to this mechanism (29). However, only half
f the atypical AFLs in Group 1 (9 of 18) occurred in the
A, and 28% of the patients had documentation of AFL
ven before the PVAI. Furthermore, in our “control” group,
he rate of LA AFL after PVAI was only 1.2% (n  13),
nd of these patients, 31% (n  4) had evidence of AFL
efore PVAI. Therefore, we believe that PVAI itself does
ot explain the occurrence of the vast majority of post-
rocedural AFL.
linical implications. Patients with PCS are at increased
isk of developing AFL recurrence after successful PVAI.
his clinical finding is relevant when counseling these
atients before PVAI. In this subgroup, concomitant
FL ablation with PVAI should be considered to max-
mize cure with a single procedure. After isolating PVs,
n attempt at inducing AFL with programmed atrial
timulation would be reasonable in PCS patients present-
ng with AF and AFL. Furthermore, in patients with
CS it is important to detect the nature of the recurrent
rrhythmia after PVAI. Careful documentation of the
rrhythmia in this group would be helpful when planning
urther ablative treatment.
ONCLUSIONS
n patients with PCS, post-PVAI AF recurrence is similar
o patients without PCS. However, post-PVAI AFL recur-
ence is higher in PCS patients. Additional AFL ablation is
eeded to cure this subset of patients.eprint requests and correspondence: Dr. Andrea Natale, Sec-
ion of Pacing and Electrophysiology, Cleveland Clinic Founda-
ion, Desk F15, 9500 Euclid Avenue, Cleveland, Ohio 44195.
-mail: natalea@ccf.org.
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